Eagle Capital Growth Fund director buys 1,025 shares at $10 each

Eagle Capital Growth Fund, Inc. director reported buying additional shares of the fund’s common stock.

Rhea-AI Filing Summary

Eagle Capital Growth Fund, Inc. director reported buying additional shares of the fund’s common stock. On December 1, 2025, the reporting person purchased 1,000 shares of common stock at $10 per share. On December 2, 2025, they purchased another 25 shares at $10 per share. After these open-market purchases, the director beneficially owned 17,862.96 shares of Eagle Capital Growth Fund common stock, held directly.

Insider Trade Summary

Net Buyer: 1,025 shares

Net Buy 2 txns

Insider Zalenko Neal F.

Role Director

Bought 1,025 shs ($10K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	25	$10.00	$250.00
Purchase	Common Stock	1,000	$10.00	$10K

Holdings After Transaction: Common Stock — 17,862.96 shares (Direct)

FAQ

What insider transaction did Eagle Capital Growth Fund (GRF) disclose?

A director of Eagle Capital Growth Fund, Inc. disclosed open-market purchases of the company’s common stock on two consecutive days in December 2025.

How many Eagle Capital Growth Fund (GRF) shares were purchased in this Form 4?

The director purchased 1,000 shares of common stock on December 1, 2025 and 25 shares on December 2, 2025, for a total of 1,025 shares.

At what price were the GRF shares bought by the insider?

Both transactions were reported at a purchase price of $10 per share of Eagle Capital Growth Fund common stock.

How many Eagle Capital Growth Fund (GRF) shares does the director own after these trades?

Following the reported transactions, the director beneficially owned 17,862.96 shares of Eagle Capital Growth Fund common stock.

What is the insider’s relationship to Eagle Capital Growth Fund (GRF)?

The reporting person is identified as a director of Eagle Capital Growth Fund, Inc. and filed individually as one reporting person.

Were any derivative securities reported for Eagle Capital Growth Fund (GRF)?

The filing’s derivative securities table is included but shows no derivative securities acquired, disposed of, or beneficially owned in this report.

Who signed the insider report for Eagle Capital Growth Fund (GRF)?

The report was signed by Carrie Leahy as Attorney-in-Fact under a power of attorney on December 3, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/03/2025 - 05:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zalenko Neal F.

(Last) (First) (Middle)

225 E. MASON STREET

SUITE 802

(Street)

MILWAUKEE WI 53202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EAGLE CAPITAL GROWTH FUND, INC. [ GRF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/01/2025		P		1,000	A	$10	17,837.96	D
Common Stock	12/02/2025		P		25	A	$10	17,862.96	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Carrie Leahy, Attorney-in-Fact by Power of Attorney	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.